Closed loop impedance-based cardiac resynchronization therapy systems, devices, and methods

• US 8,295,927 B2
• Filed: 10/20/2008
• Issued: 10/23/2012
• Est. Priority Date: 05/25/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Ding, Jiang, Yu, Yinghong, Spinelli, Julio C., Stahmann, Jeffrey E.
• Primary Examiner(s): Bertram, Eric D.
• Application Number:
  US12/254,631
• Publication Number:
  US 20090048637A1
• Time in Patent Office: 1,464 Days
• Field of Search: 607/9, 607/17
• US Class Current: 607/9
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

This document discusses, among other things, systems, devices, and methods measure an impedance and, in response, adjust an atrioventricular (AV) delay or other cardiac resynchronization therapy (CRT) parameter that synchronizes left and right ventricular contractions. A first example uses parameterizes a first ventricular volume against a second ventricular volume during a cardiac cycle, using a loop area to create a synchronization fraction (SF). The CRT parameter is adjusted in closed-loop fashion to increase the SF. A second example measures a septal-freewall phase difference (PD), and adjusts a CRT parameter to decrease the PD. A third example measures a peak-to-peak volume or maximum rate of change in ventricular volume, and adjusts a CRT parameter to increase the peak-to-peak volume or maximum rate of change in the ventricular volume.

Claims

1. A machine-assisted method comprising:

measuring a first impedance, during at least a portion of a cardiac cycle, between a first electrode associated with a first ventricle of a heart and a reference electrode;

measuring a second impedance, during at least the portion of the cardiac cycle, between a second electrode associated with a second ventricle of the heart, in which the second ventricle is different from the first ventricle, and the same or a different reference electrode;

measuring a phase difference between the first and second impedances; and

automatically adjusting in a closed loop manner, using the measured phase difference as an error signal, a cardiac resynchronization therapy parameter that synchronizes left and right ventricular heart contractions, the automatically adjusting tending to reduce the phase difference during a subsequent cardiac cycle, wherein the automatically adjusting comprises;

when the measured phase difference shows the second impedance leading the first impedance in phase by more than a first threshold value, then lengthening an atrioventricular (AV) delay; and

when the measured phase difference shows the first impedance leading the second impedance in phase by more than a second threshold value, then shortening the AV delay.

2. The method of claim 1, in which the first ventricle is a left ventricle, and further comprising:

if the measured phase difference shows the second impedance leading the first impedance in phase by more than a first threshold value, then making a tell ventricular (LV) offset more negative, wherein the LV offset defines a time duration by which an LV pace is scheduled to lead a right ventricular pace; and

if the measured phase difference shows the first impedance leading the second impedance in phase by more than a second threshold value, then making the LV offset more positive.

3. The method of claim 1, in which the measuring the first and second impedances includes using as the reference electrode an electrode located on a hermetically sealed housing of an implantable device or located on an insulating header extending from the housing of the implantable device.

4. The method of claim 1, in which the measuring the first and second impedances includes using as the reference electrode a supraventricular electrode of an intravascular lead.

5. The method of claim 1, in which the measuring the phase difference includes measuring a time difference between like fiducial artifacts of the first and second impedances.

6. The method of claim 1, further comprising communicating data indicative of the phase difference from an implantable medical device.

7. The method of claim 6, further comprising displaying an indication of the phase difference using an external display monitor.

8. The method of claim 1, in which the measuring the phase difference includes constraining the measuring the phase difference to occur during a time window that is measured from a cardiac depolarization.

9. A system comprising:

an implantable medical device comprising;

an impedance measurement circuit, including terminals configured to be coupled to electrodes for association with a first ventricle of a heart and a second ventricle of the heart, respectively, and configured to be coupled to a reference electrode location separate from each of the first and second ventricles, the impedance measurement circuit configured to measure a first impedance between the first ventricle and the reference electrode location, and to measure a second impedance between the second ventricle and the reference electrode location; and

a processor circuit, coupled to the impedance measurement circuit to receive signals indicative of the first and second impedances during a cardiac cycle, the processor circuit configured to perform instructions to measure a phase difference between the first and second impedances to provide an indication of a degree of synchrony or asynchrony between the first and second ventricles, the processor further configured to perform instructions to automatically adjust in a closed-loop manner, using the measured phase difference as an error signal, a cardiac resynchronization therapy parameter that synchronizes left and right ventricular heart contractions in a way that tends to reduce the phase difference during a subsequent cardiac cycle, wherein the processor circuit is further configured to perform instructions such that;

if the measured phase difference shows the second impedance leading the first impedance in phase by more than a first threshold value, then lengthening an atrioventricular (AV) delay; and

if the measured phase difference shows the first impedance leading the second impedance in phase by more than a second threshold value, then shortening the AV delay.

10. The system of claim 9, in which the processor further performs instructions such that:

if the measured phase difference shows the second impedance leading the first impedance in phase by more than a first threshold value, then making an interventricular offset more negative, wherein the interventricular offset defines a time duration by which an second ventricular pace is scheduled to lead a first ventricular pace; and

if the measured phase difference shows the first impedance leading the second impedance in phase by more than a second threshold value, then making the interventricular offset more positive.

11. The system of claim 9, in which the implantable device includes the reference electrode, and wherein the reference electrode is located on a hermetically sealed housing of an implantable device or located on an insulating header extending from the housing of the implantable device.

12. The system of claim 9, further comprising an intravascular lead including a supraventricular electrode serving as the reference electrode.

13. The system of claim 9, further comprising a telemetry circuit, coupled to the processor, the telemetry circuit configured for transmitting from the implantable device data indicative of the phase difference.

14. The system of claim 13, further comprising an external user interface device that is configured to receive the data indicative of the phase difference from the implantable device, the external user interface device including a display monitor configured to display information about the phase difference.